AIMS: To determine the molecular basis and describe the phenotype of an atypical retinal dystrophy in a family presenting with bilateral, progressive central visual loss. METHODS: Family members were examined. Investigations included Goldman perimetry, electrophysiology, and autofluorescence imaging. Candidate gene screening was performed using SSCP and sequence analysis. The proband's lymphoblastoid cells were examined for protein expression. RESULTS: Fundal examination of the proband, his mother, and brother revealed peripapillary and macular atrophy. Autosomal dominant retinal dystrophy was suspected, but less severe disease in the mother led to screening for mutations in X linked genes. A 4 bp microdeletion in exon 3 of the RP2 gene, segregating with disease, was identified. No RP2 protein expression was detected. CONCLUSION: The distinct phenotype in this family, caused by this frameshifting mutation in RP2, broadens the phenotypic spectrum of X linked retinitis pigmentosa. The absence of RP2 protein suggests that loss of protein function and not novel gain of function could account for the atypical phenotype. A definitive diagnosis of X linked retinitis pigmentosa permits appropriate genetic counselling with important implications for other family members. Clinicians should have a low threshold for screening RP2 in families with retinal dystrophy, including posterior retinal disease, not immediately suggestive of X linked inheritance.
AIMS: To determine the molecular basis and describe the phenotype of an atypical retinal dystrophy in a family presenting with bilateral, progressive central visual loss. METHODS: Family members were examined. Investigations included Goldman perimetry, electrophysiology, and autofluorescence imaging. Candidate gene screening was performed using SSCP and sequence analysis. The proband's lymphoblastoid cells were examined for protein expression. RESULTS: Fundal examination of the proband, his mother, and brother revealed peripapillary and macular atrophy. Autosomal dominant retinal dystrophy was suspected, but less severe disease in the mother led to screening for mutations in X linked genes. A 4 bp microdeletion in exon 3 of the RP2 gene, segregating with disease, was identified. No RP2 protein expression was detected. CONCLUSION: The distinct phenotype in this family, caused by this frameshifting mutation in RP2, broadens the phenotypic spectrum of X linked retinitis pigmentosa. The absence of RP2 protein suggests that loss of protein function and not novel gain of function could account for the atypical phenotype. A definitive diagnosis of X linked retinitis pigmentosa permits appropriate genetic counselling with important implications for other family members. Clinicians should have a low threshold for screening RP2 in families with retinal dystrophy, including posterior retinal disease, not immediately suggestive of X linked inheritance.
Authors: J Paul Chapple; Alison J Hardcastle; Celene Grayson; Keith R Willison; Michael E Cheetham Journal: Invest Ophthalmol Vis Sci Date: 2002-06 Impact factor: 4.799
Authors: Radha Ayyagari; F Yesim Demirci; Jiafan Liu; Eve L Bingham; Heather Stringham; Laura E Kakuk; Michael Boehnke; Michael B Gorin; Julia E Richards; Paul A Sieving Journal: Genomics Date: 2002-08 Impact factor: 5.736
Authors: S S Bhattacharya; A F Wright; J F Clayton; W H Price; C I Phillips; C M McKeown; M Jay; A C Bird; P L Pearson; E M Southern Journal: Nature Date: 1984 May 17-23 Impact factor: 49.962
Authors: Artur V Cideciyan; Malgorzata Swider; Tomas S Aleman; Alexander Sumaroka; Sharon B Schwartz; Marisa I Roman; Ann H Milam; Jean Bennett; Edwin M Stone; Samuel G Jacobson Journal: Invest Ophthalmol Vis Sci Date: 2005-12 Impact factor: 4.799
Authors: Thiran Jayasundera; Kari E H Branham; Mohammad Othman; William R Rhoades; Athanasios J Karoukis; Hemant Khanna; Anand Swaroop; John R Heckenlively Journal: Arch Ophthalmol Date: 2010-07
Authors: Tom R Webb; David A Parfitt; Jessica C Gardner; Ariadna Martinez; Dalila Bevilacqua; Alice E Davidson; Ilaria Zito; Dawn L Thiselton; Jacob H C Ressa; Marina Apergi; Nele Schwarz; Naheed Kanuga; Michel Michaelides; Michael E Cheetham; Michael B Gorin; Alison J Hardcastle Journal: Hum Mol Genet Date: 2012-05-22 Impact factor: 6.150
Authors: David A Parfitt; Amelia Lane; Conor Ramsden; Katarina Jovanovic; Peter J Coffey; Alison J Hardcastle; Michael E Cheetham Journal: Biochem Soc Trans Date: 2016-10-15 Impact factor: 5.407